Consequently, the benefit of IL-1β blockade in this model paved the way to clinical trials of patients with established HF, in which the IL-1 blockers appear to improve cardiorespiratory fitness, a surrogate for contractile and diastolic reserve [15,16,17,18]. Here, IL1B is linked to hydrops fetalis.